まとめ
クロランフェニコール耐性サルモネラ・タイファイは1971年にサイゴンで発生した. アンピシリンやトリメトプリム・スルファメトキサゾールなどの代替抗生物質は,これらの耐性菌株に対して有効であることが示されました.
科学分野:
- 微生物学 微生物学とは
- 感染症 感染症は感染症です.
- 薬理学 薬理学とは
背景:
- バクテリアの病原体における抗生物質耐性の出現は,公衆衛生に重大な脅威をもたらす.
- サルモネラ・タイファイは,全身の感染症であるタイホイド熱の主要な原因です.
- クロランフェニコルは,耐性菌の出現前に,タイフォイド熱の主要な治療法でした.
研究 の 目的:
- サイゴンにおけるクロラムフェニコル耐性サルモネラ・タイファイの流行を調査する.
- これらの耐性菌株の代替抗生物質に対する感受性を評価する.
- 耐性菌株による感染症に対するさまざまな治療法の臨床的有効性を評価する.
主な方法:
- 臨床サンプルからサルモネラ・タイファイ菌株の分離と識別.
- クロラムフェニコルの耐性を決定するためのアガーディスク拡散法.
- クロランフェニコルおよび他の抗生物質の最小抑制濃度 (MIC) を決定するためのブローチ・希釈法.
- クロランフェニコル,アンピシリン,トリメトプリム-スルファメトキサゾールで治療された患者の臨床応答評価.
主要な成果:
- サイゴン (1971) で孤立したサルモネラ・タイフィ菌株の46%がクロラムフェニコール耐性を示した.
- 試験した菌株の37%はクロラムフェニコルのMICが高かった (>250μg/ml).
- すべての耐性菌株は,アンピシリン (0.4μg/mlMIC) とトリメトプリム・スルファメトキサゾールに対して感受性があった.
結論:
- サルモネラ・タイファイのクロラムフェニコル耐性は,1971年のサイゴンでの重要な問題でした.
- アンピシリンとトリメトプリム-スルファメトキサゾールは,クロラムフェニコール耐性タイフォイド熱の治療に有効な治療の代替品です.
- この発見は,抗生物質耐性パターンの継続的な監視の必要性を強調しています.
関連する概念動画
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:19Acid Mine Drainage
Mining activities that disturb sulfide-rich rocks, particularly those containing pyrite (FeS₂), initiate a cascade of geochemical and microbiological processes with serious environmental implications. When exposed to air and water, pyrite undergoes oxidation, releasing sulfate, ultimately forming sulfuric acid and mobilizing heavy metals into surrounding water systems. This phenomenon, known as acid mine drainage (AMD), results in low pH waters laden with toxic elements that threaten aquatic...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:24iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...